You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

I am a:
${ profile.name.substring(0, profile.name.length - 1) }
Request Info
#carousel-content-0 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-content-0 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }

Customized Testing for Your Institution

No matter what your testing needs, we’ve got the right fit. If you’re a Laboratory Professional, Health Care Provider, or Health Care Executive, Cepheid’s menu of nearly 30 CE-IVD tests and platform flexibility means that faster answers are available in every setting. For Healthcare-Associated Infections, Critical Infectious Diseases, Virology, Sexual Health, or Oncology, Cepheid is the ideal diagnostic partner for improved clinical decision making and patient care.

Better Flexibility, Scalability & Consolidation.
Whenever You Need It.


Only Cepheid’s GeneXpert® System can deliver game-changing flexibility with better answers. In 2006, Cepheid shifted the industry paradigm by taking the complexity out of the system and integrating it into an automated, easy to use, cartridge that delivers highly accurate PCR results.
 

Now, true platform consolidation and faster, more accurate results are a reality.

#carousel-content-4 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-content-4 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }
VIDEO

On-Demand Testing with the Scalable GeneXpert® System: An Introduction    

Cepheid is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. 

Watch Video

Impact Briefs

Fighting the Challenge of CPE –  The Federation of Infection Societies Annual Conference at the International Convention Centre in Birmingham was the venue for the symposium Fighting the challenge of CPE, which took a look at one hospital’s approach to addressing the challenges posed by carbapenamase-producing Enterobacteriaceae (CPE).

Download Brief

Lancaster General Health implements leading-edge technology and automation using a GeneXpert® Infinity System to consolidate molecular testing and improve patient care.

Download Brief

The GeneXpert® Infinity demonstrates better operational efficiencies and time to results when compared to other automated molecular platforms for the detection of CT/NG

Download Brief

Webinar

#carousel-content-6 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-content-6 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }
Cepheid Shakeups: New Technologies and Partnering for Innovation
WEBINAR

Cepheid Shakeups: New Technologies and Partnering for Innovation

At the recent 2019 ECCMID conference held in Amsterdam, Dr Fred Tenover (Vice President of Scientific Affairs here at Cepheid) gave a very well received talk about new Cepheid technologies as well as some recent partnerships which are contributing to the next innovations we are bringing to market. Some of the exciting topics he covered included, updates to our MRSA and Group B Strep products, new technologies utilized in Cepheid TB products such as 10-coulour detection, melt cure analysis and the upcoming launch of our TB-XDR cartridge as well as the official launch of the Cepheid FleXible cartridge program. We appreciate that not everyone was able to attend the live talk at ECCMID and through popular demand and interest we have recorded his talk as a Webinar to make it available more widely for our customers.

Simplification of testing and treatment in the quest to eliminate hepatitis C infection
WEBINAR

Simplification of testing and treatment in the quest to eliminate hepatitis C infection

Globally, 71 million people are living with hepatitis C virus (HCV) infection, but the burden of HCV continues to increase. Between 2015 and 2030, WHO targets include reducing new HCV infections by 80% and HCV deaths by 65%, and increasing HCV diagnoses from <20% to 90% and the number of eligible persons receiving HCV treatment from <10% to 80%. To achieve these targets, targeted interventions are needed to enhance HCV testing, linkage to care, and treatment (“the HCV care cascade”). This presentation reviews available evidence on strategies that have been successfully used to enhance HCV testing, linkage to care.

The Neglected STI: Trichomonas vaginalis
WEBINAR

The Neglected STI: Trichomonas vaginalis

Among US women ages 14-49 the prevalence of Trichomonas vaginalis infection is estimated to be 2.3 million, though 85% of women found to have trichomoniasis report no symptoms. With varied complications such as increased risk of HSV-2/HIV acquisition, pelvic inflammatory disease and pre-term birth it has become increasingly important to identify and treat these patients quickly. This webinar will explore the renewed interest to screen and diagnose T. vaginalis in women. It will examine current testing methods available and provide updates regarding treatment options.

Chlamydia and Gonorrhea testing in the ED and the Need for Evidence Based Medicine
WEBINAR

Chlamydia and Gonorrhea testing in the ED and the Need for Evidence Based Medicine

In this webinar, Dr. Larissa May will discuss the diagnosis of sexually transmitted infections in the Emergency Department, the need for evidence-based medicine, and how same-visit treatment and management can be facilitated with on-demand testing for CT/NG.

Key Links

#carousel-content-7 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-content-7 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }
GeneXpert Family of Systems

GeneXpert System technology is the cornerstone of our approach to molecular diagnostics.

Molecular Testing

With 20 FDA-cleared tests, Cepheid is the ideal diagnostic partner for improved clinical decision making and patient care.

Laboratory Professionals

It’s time for you to get better answers. That’s why Cepheid’s solutions work as hard as you do. We know that at the core of providing excellent laboratory service, there are laboratorians like you.

Healthcare Professionals

Our broad offering of easy-to-use tests, systems, and resources are created with you and your patients’ needs in mind.

Connect To Better Outcomes

Request Info
Back to Top